Global Movement Disorder Market Valuable Growth Prospects and Insights on Future Scenario with Top Key Players- Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation and Mayo Clinic.

Growing prevalence of neurological diseases has led to surge in demand for managing mental disorders. In addition, Manufacturers are increasingly focusing on incorporating advanced features in the medical devices for the treatment of the neurological diseases, which is projected to impact the global market growth of movement disorder. Fact.MR states that the global market of movement disorder is projected to reflect a CAGR of 11.1% over the forecast period, 2017-2026.

Get Free Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=329

Inability to generate movements affects the functioning of nerves, brain and the spinal cord adversely. Neurological disorders has led to surge in diseases such as trauma, convulsive diseases, cerebrovascular diseases, brain tumors and degenerative diseases. Growing prevalence of such mental disorders impact the cognitive abilities and lead to increasing prevalence of insomnia, depression, swallowing, inability to chew and speaking. Surge in awareness attributed to increasing prevalence of the neurological diseases is expected to impact growth of the global movement disorders market positively.

Sales to Remain High in Hospitals

Treatment of various neurological diseases has led to surge in adoption of the rechargeable deep brain stimulator devices. The rechargeable deep brain stimulator devices is projected to outsell the non-rechargeable deep brain stimulator devices globally. On the basis of product type, the rechargeable deep brain stimulator devices is projected to witness the highest growth in terms of revenue, recording more than US$ 500 Mn by 2026-end. On the other hand, the non-rechargeable deep brain stimulator devices product type segment is projected to reflect a robust CAGR throughout the forecast period.

By end user, the hospitals segment is projected to represent a robust revenue growth, accounting for less than US$ 100 Mn by 2017-end. In contrary to this, the clinics end user segment is projected to reflect a healthy CAGR during the forecast period. In terms of revenue, the parkinson’s disease application segment is projected to witness a significant revenue growth, recording more than US$ 400 Mn by 2026-end. By 2026-end, the dystonia application segment is projected to witness the fastest growth during the forecast period.

FDA Approval to Boost Sales of Medications

Medications and treatments approved by FDA is also expected to impact growth of the global movement disorder market. Xadago (safinamide) tablets and Ingrezza capsules are two drugs that have recently cleared the FDA pipeline. Ingrezza capsules have recently received approval for treatment of dyskinesia and Xadago (safinamide) tablets have received approval of Parkinson’s disease. In addition, the FDA has also approved implantation of brain to reduce the tremor symptoms. These factors are further expected to boost growth of the global movement disorders market.

Advanced Features to Impact Growth of the Global Market

In order to gain a competitive edge, various companies operating in the global movement disorder market are focusing on product innovation and developments. Manufacturers are mainly concentrating on incorporating advanced technology in the medical devices for faster recovery and improved results. Equipped with the advanced features such as sensors, 360-degree stabilizing solutions and cloud technology. Parkinson’s spoon equipped with advanced technological features enable the end users to retrieve and store information regarding the status of the unwanted tremors and generates the algorithm of tremor patterns for optimal stabilization. Moreover, the manufacturers operating in the global market are offering the electronic stabilizing handle, which comprises everyday spoon, spork, soup spoon and a fork. Bound to these factors, the global movement disorders market is expected to witness significant growth during the forecast period.

Browse Full Report with TOC @ https://www.factmr.com/report/329/movement-disorder-market

On the other hand, various factors continue to impact growth of the global movement disorders market negatively. Lack of investment in research and development will continue to inhibit growth of the global movement disorder market. In addition, slow approval of the medications developed is further likely to impact growth of the global market negatively. Moreover, poor method of therapeutics conducted continues to pose significant challenges towards growth of the global market.

Parkinson ’s disease to Represent a Leading Segment

Growing need for medical devices with the uninterrupted functioning for treatment of the neurological disorders has led to an upsurge in adoption of rechargeable deep brain stimulator devices. On the basis of product type, the rechargeable deep brain stimulator devices segment is expected to generate significant revenues, accounting for a value of over US$ 500 Mn by the end of 2026. However, the non-rechargeable deep brain stimulator devices product type segment is expected to register the highest CAGR during the forecast period.

Based on end user, the hospitals segment is expected to represent the highest revenue growth, recording a value of less than US$ 100 Mn by the end of 2017. On the other hand, the clinics end user segment is expected to register a robust through 2026.

By application, the Parkinson’s disease segment is expected to represent a significant revenue growth, accounting for a value of over US$ 400 Mn by the end of 2026. In contrary to this, the dystonia application segment is expected to register a healthy CAGR throughout the forecast period.

Competition Tracking

Leading market players operating in the global movement disorder market include Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation and Mayo Clinic.

Table of Content:

Chapter 1 Global Outlook

Chapter 2 Global Movement Disorder Market - Executive Summary

Chapter 3 Global Movement Disorder Market Overview
3.1 Introduction
      3.1.1 Global Movement Disorder Market Taxonomy
      3.1.2 Global Movement Disorder Market Definition
3.2 Global Movement Disorder Market Size (US$ Mn) and Forecast, 2012-2026
      3.2.1 Global Movement Disorder Market Y-o-Y Growth
3.3 Global Movement Disorder Market Dynamics
3.4 Supply Chain
3.5 Cost Structure
3.6 Technology Roadmap
3.7 Disease Epidemiology
3.8 Product Lifecycle
3.9 Key Regulations
3.10 PESTL Analysis
3.11 List of Service Providers
3.12 Key Participants Market Presence (Intensity Map) By Region

Chapter 4 Global Movement Disorder Market Analysis and Forecast 2012-2026
4.1 Global Movement Disorder Market Size and Forecast by Product Type, 2012-2026
      4.1.1 Rechargeable Deep Brain Stimulator Devices Market Size and Forecast, 2012-2026
              4.1.1.1 Revenue (US$ Mn) Comparison, By Region
              4.1.1.2 Market Share Comparison, By Region
              4.1.1.3 Y-o-Y growth Comparison, By Region
      4.1.2 Non-rechargeable Deep Brain Stimulator Devices Market Size and Forecast, 2012-2026
              4.1.2.1 Revenue (US$ Mn) Comparison, By Region
              4.1.2.2 Market Share Comparison, By Region
              4.1.2.3 Y-o-Y growth Comparison, By Region
4.2 Global Movement Disorder Market Size and Forecast by End User, 2012-2026

Continued……………..

Buy This Report @ https://www.factmr.com/checkout/317/S

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market Insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/

This release was published on openPR.